Cytokine & Growth Factor Reviews

Papers
(The TQCC of Cytokine & Growth Factor Reviews is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board171
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases142
COVID-19: From emerging variants to vaccination129
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions126
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs112
Unveiling cytokine charge disparity as a potential mechanism for immune regulation109
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy96
Editorial Board91
Editorial Board86
Editorial Board81
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism77
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects71
Metabolic Regulation of cGAS-STING Signaling in the Tumor Microenvironment: Dual Immune Roles and Therapeutic Implications70
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances67
Participation of interferons in psoriatic inflammation65
Cytokine symphony: Deciphering the tumor microenvironment and metastatic axis in oral cancer63
Molecular mechanisms of regulation of IL-1 and its receptors57
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection56
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration55
Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation53
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets51
Exogenous drug-induced mouse models of atopic dermatitis51
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer50
TGF-β mediated drug resistance in solid cancer48
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review46
Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles42
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis41
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis41
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-239
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases39
Multifaceted role of CD14 in innate immunity and tissue homeostasis37
MDSCs might be “Achilles heel” for eradicating CSCs36
Exosomes as a modulator of immune resistance in human cancers36
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling34
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?34
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells34
Editorial Board33
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy32
The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential32
Decoding the roles of heat shock proteins in liver cancer31
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands31
Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression30
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases29
B cell-activating factor and its targeted therapy in autoimmune diseases29
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment29
Netrin-1: An emerging player in inflammatory diseases28
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies28
Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights27
The impact of adipokines on vascular networks in adipose tissue26
From senescence to scarring: Exploring TGF-β signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis26
Forgetting COVID-19 – Introduction to the special issue26
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer24
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities23
Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation23
mTOR in programmed cell death and its therapeutic implications22
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance22
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease22
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism22
Glioblastoma-associated macrophages: A key target in overcoming glioblastoma therapeutic resistance21
Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy21
Editorial Board21
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression21
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders20
Cholecystokinin and gastrin as immune modulating hormones: Implications and applications20
Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk20
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression20
0.034655094146729